Trial intelligence / Profile preview

Retinal thickness in glaucoma patients using prostaglandin eye drops undergoing trabeculectomy

RBR-5y44mmjCompleted

Sponsor
Universidade Federal de Goiás
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of mitomycin c in Glaucoma (2 arms), sponsored by Universidade Federal de Goiás. Primary endpoint: Retinal thickness. Started Jan 2021; status: completed.

02

Drugs

mitomycin c
03

Conditions

Glaucoma

Beyond the preview

Go deeper on RBR-5y44mmj.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-5y44mmj.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call